Standard BioTools Inc.LABNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank21
3Y CAGR+4.7%
5Y CAGR-12.6%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+4.7%/yr
vs -12.0%/yr prior
5Y CAGR
-12.6%/yr
Recent acceleration
Acceleration
+16.7pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$42.54M-49.5%
2024$84.26M+67.0%
2023$50.45M+36.2%
2022$37.05M-46.6%
2021$69.37M-16.7%
2020$83.33M+29.6%
2019$64.28M+4.3%
2018$61.65M+18.6%
2017$51.98M-11.0%
2016$58.44M-